Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Tumor Progression02:07

Tumor Progression

6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Images: Skin manifestations and radiographic findings of anti-SAE1 positive dermatomyositis.

ACR open rheumatology·2026
Same author

Pulmonary Squamous Cell Carcinoma Dissemination Through Air Spaces (STAS): Clinicopathologic Findings in Different Tumor Origins.

Pathophysiology : the official journal of the International Society for Pathophysiology·2026
Same author

Predicting clinical sensitivities of PDGFRA exon 18 mutations to imatinib and avapritinib to optimize gastrointestinal stromal tumor treatment.

Cancer research communications·2026
Same author

Comprehensive Clinicopathologic and Molecular Analysis of Mesenchymal Tumors With BRAF Fusions.

Genes, chromosomes & cancer·2026
Same author

A subset of high-grade sarcomas with myogenic differentiation are associated with recurrent FGFR fusions.

The journal of pathology. Clinical research·2026
Same author

Prognostic Impact of MYC/TP63 Molecular Subtypes in Adenoid Cystic Carcinoma: A Meta-Analysis.

Cancers·2026
Same journal

Biphenotypic Sinonasal Sarcoma With a Novel PAX3::MAML2 Fusion.

Genes, chromosomes & cancer·2026
Same journal

An Affordable and Efficient In-House Approach for Detecting Gene Fusions in Bone and Soft Tissue Tumors Using a Custom Capture Panel and Nanopore Sequencing.

Genes, chromosomes & cancer·2026
Same journal

PKMYT1 in Cancer: Beyond Cell Cycle Checkpoints to Context-Dependent Therapeutic Vulnerability.

Genes, chromosomes & cancer·2026
Same journal

Associations of Dietary Intake Traits and Aging Indicators With Colorectal Cancer: A Mendelian Randomization Study.

Genes, chromosomes & cancer·2026
Same journal

Primary Tumor-Associated Loss of the Y Chromosome and Clinical Outcome in Metastatic Colorectal Cancer.

Genes, chromosomes & cancer·2026
Same journal

Cytogenetic and Molecular Analysis of a "Double-Hit" RUNX1 Including a RUNX1 p.Trp279* and a Cryptic Novel t(6;21)(q25;q22)/RUNX1::ARID1B in Acute Myeloid Leukemia.

Genes, chromosomes & cancer·2026
See all related articles

Related Experiment Video

Updated: Jun 6, 2025

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.1K

Malignant Bone-Forming Neoplasm With NIPBL::BEND2 Fusion.

Nooshin K Dashti1,2, George Matcuk3, Abbas Agaimy4

  • 1Department of Pathology and Laboratory Medicine, Dartmouth Health Medical Center, Lebanon, New Hampshire, USA.

Genes, Chromosomes & Cancer
|November 28, 2024
PubMed
Summary
This summary is machine-generated.

This study reports a rare, aggressive bone cancer in a young man with an unusual NIPBL::BEND2 gene fusion. Molecular analysis confirmed it as high-grade osteosarcoma, not a phosphaturic mesenchymal tumor, highlighting the need for genetic testing in challenging bone tumor cases.

Keywords:
BEND2NIPBLosteoblastic tumorosteosarcomaphosphaturic mesenchymal tumorsarcoma

More Related Videos

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

1.9K
Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

6.8K

Related Experiment Videos

Last Updated: Jun 6, 2025

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.1K
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

1.9K
Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

6.8K

Area of Science:

  • Orthopedic Oncology
  • Skeletal Pathology
  • Molecular Diagnostics

Background:

  • Conventional high-grade osteosarcomas present with aggressive features, but rare variants exhibit unusual histology, necessitating molecular confirmation.
  • Sclerosing or osteoblastoma-like osteosarcomas can be diagnostically challenging due to non-specific histopathology.
  • Accurate diagnosis is critical for appropriate management and prognosis of bone tumors.

Purpose of the Study:

  • To characterize an aggressive acral bone-forming tumor with unusual initial presentation and histopathology.
  • To identify the molecular drivers of the tumor and determine its precise classification.
  • To evaluate the clinical behavior and treatment response of this rare osteosarcoma subtype.

Main Methods:

  • Histopathological examination of tumor biopsies and surgical resection specimens.
  • Immunohistochemistry for SATB2.
  • RNA sequencing to identify gene fusions (NIPBL::BEND2).
  • In situ hybridization for FGF23.
  • DNA methylation profiling with unsupervised clustering and UMAP analysis.

Main Results:

  • The tumor initially presented as a sclerotic lesion mimicking osteoblastoma but recurred aggressively.
  • Histology evolved to high-grade osteosarcoma with lace-like osteoid deposition and uniform epithelioid cells.
  • Molecular analysis revealed a NIPBL::BEND2 fusion, previously associated with phosphaturic mesenchymal tumor (PMT).
  • DNA methylation profiling confirmed the tumor's classification as high-grade osteosarcoma, distinct from PMT.
  • The patient achieved disease remission after chemotherapy following below-knee amputation.

Conclusions:

  • The NIPBL::BEND2 fusion can occur in aggressive, high-grade osteosarcomas, expanding its known spectrum.
  • Molecular profiling is essential for accurate diagnosis of challenging bone tumors, differentiating them from entities like PMT.
  • This case highlights the potential for recurrent fusions in diverse bone tumor types and underscores the need for further research.